Long Term Outcomes of Femorofemoral Crossover Bypass Grafts

다국어 초록 (Multilingual Abstract)

Purpose: Femorofemoral crossover bypass (FCB) is a good procedure for patients with unilateral iliac artery disease. There are many articles about the results of FCB, but most of them were limited to 5 years follow-up. The purpose of our study was to analysis the results of FCB with a 10-year follow-up period.
Materials and Methods: Between January 1995 and December 2010, 133 patients were operated in Samsung Medical Center (median follow-up: 58.8 months). We retrospectively analysed patient characteristics, the preoperative treatment, the operative procedure, and material used.
Results: The indications for FCB were claudication in 110 and critical limb ischemia in 23 patients. Three patients were died due to myocardiac infarction, intracranial hemorrhage, and acute respiratory failure within 30 days after surgery. The oneyear primary and secondary patency rates were 89% and 97%, the 5-year primary and secondary patency rates were 70% and 85%, and the 10-year primary and secondary patency rates were 31% and 67%. The 5-year and 10-year limb salvage rates were 97% and 95%, respectively.
Conclusion: Our long term analysis suggests that FCB might be a valuable alternative treatment modality in patients with unilateral iliac artery disease.

참고문헌 (Reference)

1 Thuijls G, "Usefulness and applicability of femorofemoral crossover bypass grafting" 22 : 663-667, 2008

2 Park UJ, "Thromoboagiitis Obliterans (TAO)" 3 : 1-7, 2010

3 Mii S, "Role of femorofemoral crossover bypass grafting for unilateral iliac atherosclerotic disease:a comparative evaluation with anatomic bypass" 35 : 453-458, 2005

4 Freeman NE, "Operations on large arteries; application of recent advances" 77 : 229-233, 1952

5 Ricco JB, "Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease" 47 : 45-53, 2008

6 Capoccia L, "Is femorofemoral crossover bypass an option in claudication?" 24 : 828-832, 2010

7 Eiberg JP, "Fluoropolymer-coated dacron versus PTFE grafts for femorofemoral crossover bypass: randomised trial" 32 : 431-438, 2006

8 Schneider JR, "Femorofemoral versus aortobifemoral bypass:outcome and hemodynamic results" 19 : 43-55, 1994

9 Mingoli A, "Femorofemoral bypass grafts: factors influencing long-term patency rate and outcome" 129 : 451-458, 2001

10 Nolan KD, "Femorofemoral bypass for aortofemoral graft limb occlusion: a tenyear experience" 19 : 851-856, 1994

11 Kim YW, "Factors affecting the long-term patency of crossover femorofemoral bypass graft" 30 : 376-380, 2005

12 Pursell R, "Critical appraisal of femorofemoral crossover grafts" 92 : 565-569, 2005

13 Jongkind V, "A systematic review of endovascular treatment of extensive aortoiliac occlusive disease" 52 : 1376-1383, 2010